Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From Gastrointestinal (GI) Adverse Events While on Mycophenolate Mofetil Therapy (MMF) Therapy

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions

Kidney TransplantationLiver Transplantation

Interventions

DRUG

Enteric-coated Mycophenolate sodium (EC-MPS)

Trial Locations (1)

Novartis, Basel